Citation Impact
Citing Papers
2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2017 Standout
Guidelines for the Management of Spontaneous Intracerebral Hemorrhage
2015 Standout
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update 2014
2015 Standout
Cancer statistics, 2022
2022 Standout
Cancer statistics, 2023
2023 Standout
Comparison of prothrombin time (INR) results and main characteristics of patients on warfarin treatment in primary health care centers and anticoagulation clinics
2013 StandoutNobel
Basal cell carcinomas: attack of the hedgehog
2008 Standout
Cancer statistics, 2017
2017 Standout
Cancer statistics, 2020
2020 Standout
Cancer statistics, 2024
2024 Standout
Cancer statistics, 2019
2019 Standout
Cancer statistics, 2018
2018 Standout
Cancer Statistics, 2021
2021 Standout
Mutation and homozygous deletion analyses of genes that control the G1/S transition of the cell cycle in skin melanoma: p53, p21, p16 and p15
2005
Chemosensitivity linked to p73 function
2003 StandoutNobel
Dose-Finding Study of Rivaroxaban in Hemodialysis Patients
2015
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies
2008 Standout
Edoxaban versus enoxaparin–warfarin in patients undergoing cardioversion of atrial fibrillation (ENSURE-AF): a randomised, open-label, phase 3b trial
2016
A common polymorphism acts as an intragenic modifier of mutant p53 behaviour
2000 StandoutNobel
Treatment of Warfarin-Associated Intracerebral Hemorrhage: Literature Review and Expert Opinion
2007
Transgenics, toxicity and therapeutics in rodent models of mutant SOD1-mediated familial ALS
2008
Role for the p53 homologue p73 in E2F-1-induced apoptosis
2000 StandoutNatureNobel
p53 polymorphisms: cancer implications
2009
Evidence-Based Management of Anticoagulant Therapy
2012
Papillomaviruses Causing Cancer: Evasion From Host-Cell Control in Early Events in Carcinogenesis
2000 Standout
Mechanisms Underlying Inflammation in Neurodegeneration
2010 Standout
Glutamate uptake
2001 Standout
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for reporting observational studies
2014 Standout
Antithrombotic Therapy for VTE Disease
2016 Standout
Relative survival in patients with chronic-phase chronic myeloid leukaemia in the tyrosine-kinase inhibitor era: analysis of patient data from six prospective clinical trials
2015
Prophylactic doses of low-molecular weight heparin as periprocedural bridging therapy in mechanical heart valve patients
2017
iASPP preferentially binds p53 proline-rich region and modulates apoptotic function of codon 72–polymorphic p53
2006
Comparison of evidence on harms of medical interventions in randomized and nonrandomized studies
2006
Genes other than BRCA1 and BRCA2 involved in breast cancer susceptibility
2002
Concomitant use of warfarin and ticagrelor as an alternative to triple antithrombotic therapy after an acute coronary syndrome
2014
Skin Cancers after Organ Transplantation
2003 Standout
CYP3A4 Polymorphisms--Potential Risk Factors for Breast and Prostate Cancer: A HuGE Review
2004
Antithrombotic Therapy for VTE Disease
2012 Standout
Blinded by the Light: The Growing Complexity of p53
2009 Standout
GRADE guidelines: 3. Rating the quality of evidence
2011 Standout
A randomized, double‐blind study of certoparin vs. unfractionated heparin to prevent venous thromboembolic events in acutely ill, non‐surgical patients: CERTIFY Study
2010
‘Mendelian randomization’: can genetic epidemiology contribute to understanding environmental determinants of disease?*
2003 Standout
Aortic valve replacement with mechanical vs. biological prostheses in patients aged 50–69 years
2015
Male breast cancer
2006 Standout
Live or let die: the cell's response to p53
2002 Standout
Genetics of amyotrophic lateral sclerosis
1996
Mitochondrial Membrane Permeabilization in Cell Death
2007 Standout
Tobacco Smoke Carcinogens and Lung Cancer
1999 Standout
An open-label comparison of the efficacy and safety of certoparin versus unfractionated heparin for the prevention of thromboembolic complications in acutely ill medical patients: CERTAIN
2010
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies
2007 Standout
A novel risk prediction score in atrial fibrillation for a net clinical outcome from the ENGAGE AF-TIMI 48 randomized clinical trial
2016
Role of a p53 polymorphism in the development of human papilloma-virus-associated cancer
1998 Nature
p53's Believe It or Not: Lessons on Transcription-Independent Death
2003
The Molecular Epidemiology of Lung Cancer
1997
Hemorrhagic Complications of Anticoagulant and Thrombolytic Treatment
2008
The Emerging p53 Gene Family
1999 StandoutNobel
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
2013 Standout
The p53 pathway: positive and negative feedback loops
2005 Standout
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies
2007 Standout
Identification of Cyclobutane Pyrimidine Dimer-Responsive Genes Using UVB-Irradiated Human Keratinocytes Transfected with In Vitro-Synthesized Photolyase mRNA
2015 StandoutNobel
Analysis of a germ line polymorphism of the p53 gene in lung cancer patients; discrete results with smoking history
1996
Polymorphisms and colorectal tumor risk
2001
Three novel mutations and two variants in the gene for Cu/Zn superoxide dismutase in familial amyotrophic lateral sclerosis
1996 StandoutNobel
The first 30 years of p53: growing ever more complex
2009 Standout
The history and future of targeting cyclin-dependent kinases in cancer therapy
2015 Standout
The p53 codon 72 polymorphism, sunburns, and risk of skin cancer in US caucasian women
2006
Colorectal cancer screening and surveillance: Clinical guidelines and rationale?Update based on new evidence
2003 Standout
Yeast and Cancer
2004 Nobel
2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2019 Standout
2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons
2019 Standout
The ubiquitin-proteasome pathway: on protein death and cell life
1998 StandoutNobel
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2017 Standout
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies
2007 Standout
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
Works of Anders Själander being referenced
p53 Polymorphisms and Haplotypes Show Distinct Differences between Major Ethnic Groups
1996
Risk of haemorrhagic stroke in patients with oral anticoagulation compared with the general population
2003
P53 polymorphisms and haplotypes in lung cancer
1995
The D90A mutation results in a polymorphism of Cu, Zn superoxide dismutase that is prevalent in northern Sweden and Finland
1995
Efficacy and safety of anticoagulant prophylaxis to prevent venous thromboembolism in acutely ill medical inpatients: a meta‐analysis
2007
Anticoagulation control in Sweden: reports of time in therapeutic range, major bleeding, and thrombo-embolic complications from the national quality registry AuriculA
2011
Safety and efficacy of well managed warfarin
2015
P53 germ line haplotypes associated with increased risk for colorectal cancer
1995
Tyrosine kinase inhibitor usage, treatment outcome, and prognostic scores in CML: report from the population-based Swedish CML registry
2013
Bleeding complications during warfarin treatment in primary healthcare centres compared with anticoagulation clinics
2007
Outcomes in a Warfarin-Treated Population With Atrial Fibrillation
2016
Safety and Efficacy of Bridging With Low-Molecular-Weight Heparin During Temporary Interruptions of Warfarin: A Register-Based Cohort Study
2017
Estimated glomerular filtration rate is associated with major bleeding complications but not thromboembolic events, in anticoagulated patients taking warfarin
2013
p53 polymorphisms and haplotypes in breast cancer
1996